跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PEP-2
首页
药物
PEP-2
PEP-2
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Application of polypeptide PEP-Z-2 in preparation of medicine for treating renal fibrosis
申请人: INST MATERIA MEDICA CAMS
优先权: 2024
CN
Clostridium perfringens bacteriophage Clo-PEP-2 and use for inhibiting Clostridium perfringens proliferation of same
申请人: INTRON BIOTECHNOLOGY INC
优先权: 2017
CN
US
2 件公开
Methods and compositions for modulating C5-a-mediated inflammatory responses
申请人: OKADA HIDECHIKA
优先权: 2005
US
2 件公开
Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof
申请人: EPSTEIN ALAN L
优先权: 2002
US
2 件公开
Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof
申请人: EPSTEIN ALAN L
优先权: 2004
US
一种可区分鹿角胶和鹿皮胶的特征肽段及其检测方法
申请人: 南京中医药大学
优先权: 2021
CN
Method for preparing polyclonal antibody based on LCAL5-pep tiny protein related polypeptide and application of polyclonal antibody based on LCAL5-pep tiny protein related polypeptide
申请人: THE FIRST AFFILIATED HOSPITAL OF THE SECOND MILITARY MEDICAL UNIV
优先权: 2024
CN
PEP-1-G4S-KGF2 fusion protein and coding gene and application thereof
申请人: BEIJING ZHILI SHENGKE TECH CO LTD
优先权: 2020
CN
药物
反馈